Abstract:Intense efforts are being undertaken to understand the pathophysiological mechanisms triggered after brain ischemia and to develop effective pharmacological treatments. However, the underlying molecular mechanisms are complex and not completely understood. One of the main problems is the fact that the ischemic damage is time-dependent and ranges from negligible to massive, involving different cell types such as neurons, astrocytes, microglia, endothelial cells, and some blood-derived cells (neutrophils, lymphocytes, etc.). Thus, approaching such a complicated cellular response generates a more complex combination of molecular mechanisms, in which cell death, cellular damage, stress and repair are intermixed. For this reason, animal and cellular model systems are needed in order to dissect and clarify which molecular mechanisms have to be promoted and/or blocked. Brain ischemia may be analyzed from two different perspectives: that of oxygen deprivation (hypoxic damage per se) and that of deprivation of glucose/serum factors. For investigations of ischemic stroke, middle cerebral artery occlusion (MCAO) is the preferred in vivo model, and uses two different approaches: transient (tMCAO), where reperfusion is permitted; or permanent (pMCAO). As a complement to this model, many laboratories expose different primary cortical neuron or neuronal cell lines to oxygen-glucose deprivation (OGD). This ex vivo model permits the analysis of the impact of hypoxic damage and the specific response of different cell types implicated in vivo, such as neurons, glia or endothelial cells. Using in vivo and neuronal OGD models, it was recently established that mTORC1 (mammalian Target of Rapamycin Complex-1), a protein complex downstream of PI3K-Akt pathway, is one of the players deregulated after ischemia and OGD. In addition, neuroprotective intervention either by estradiol or by specific AT2R agonists shows an important regulatory role for the mTORC1 activity, for instance regulating vascular endothelial growth factor (VEGF) levels. This evidence highlights the importance of understanding the role of mTORC1 in neuronal death/survival processes, as it could be a potential therapeutic target. This review summarizes the state-of-the-art of the complex kinase mTORC1 focusing in upstream and downstream pathways, their role in central nervous system and their relationship with autophagy, apoptosis and neuroprotection/neurodegeneration after ischemia/hypoxia.

Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations.

Role of mTORC1 Controlling Proteostasis after Brain Ischemia

Inhibition of Mtor Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia

[Progress and extensive meaning of mammalian target of rapamycin involved in restoration of nervous system injury].

10 Mtor Activates Hypoxia-Inducible Factor-1 and Inhibits Neuronal Apoptosis in the Developing Rat Brain During the Early Phase after Hypoxia-Ischemia

mTOR pathway – a potential therapeutic target in stroke

Rapamycin Prevents Cerebral Stroke by Modulating Apoptosis and Autophagy in Penumbra in Rats

Inhibition of Mtor Signaling Confers Protection Against Cerebral Ischemic Injury in Acute Hyperglycemic Rats.

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

The Post-Therapeutic Effect of Rapamycin in Mild Traumatic Brain-Injured Rats Ensuing in the Upregulation of Autophagy and Mitophagy.

The role of mTOR signaling pathway in spinal cord injury.

Computational Research of Mtorc1 Inhibitor on Cerebral Ischemia-Reperfusion Injury.

Gsk-3 Beta/Mtorc1 Couples Synaptogenesis And Axonal Repair To Reduce Hypoxia Ischemia-Mediated Brain Injury In Neonatal Rats

Modulation of oxidative-nitrosative stress and inflammatory response by rapamycin in target and distant organs in rats exposed to hindlimb ischemia-reperfusion: the role of mammalian target of rapamycin

Inhibition of mTOR Alleviates Early Brain Injury After Subarachnoid Hemorrhage Via Relieving Excessive Mitochondrial Fission

mTOR/autophagy pathway in the hippocampus of rats suffering intermittent hypoxia preconditioning and global cerebral ischemia-reperfusion.

Inhibition of Mammalian Target of Rapamycin Attenuates Early Brain Injury Through Modulating Microglial Polarization after Experimental Subarachnoid Hemorrhage in Rats

Rapamycin Alleviates Neuronal Injury and Modulates Microglial Activation After Cerebral Ischemia

Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke

mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type